Smartphone app aims to ease chemotherapy symptoms for breast cancer patients

NCT ID NCT07200791

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a mobile app can help women with breast cancer better manage side effects from chemotherapy, like fatigue, nausea, and sleep problems. 74 patients will either use the app plus standard care or receive standard care alone. The app includes symptom tracking, short educational videos, and direct contact with a nurse. Researchers will measure changes in symptom severity and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
mobile application
What this could lead to
If it works, this could give breast cancer patients a simple, app-based way to track and ease chemotherapy side effects at home.
What could go wrong
This is a small, early-stage trial (74 people) testing a behavioral tool, not a drug. The app may not significantly improve symptoms or quality of life, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.